Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms
Authors:
- Mahmoud A. El-GhiatyMEMahmoud A. El-Ghiaty
- Sherif M. ShoiebSSSherif M. Shoieb
- Ayman O.S. El-KadiAEAyman O.S. El-Kadi
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Medical Hypotheses
- Vol. 144, 110033
Abstract
No abstract availableKeywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada
This publication has 129 references indexed in Scilit:
- Drug−disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activityBritish Journal of Clinical Pharmacology, 2011
- Modulation of Hepatic Cytochrome P450s by Citrobacter rodentium Infection in Interleukin-6- and Interferon-γ-Null MiceThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Pregnane X receptor is required for interleukin-6-mediated down-regulation of cytochrome P450 3A4 in human hepatocytesToxicology Letters, 2010
- Variability in drug metabolizing enzyme activity in HIV-infected patientsEuropean Journal of Clinical Pharmacology, 2010
- The First Virally Encoded Cytochrome P450Journal of Virology, 2009
- The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMCBritish Journal of Pharmacology, 2009
- Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignanciesBritish Journal of Cancer, 2007
- Gene-Specific Effects of Inflammatory Cytokines on Cytochrome P450 2C, 2B6 and 3A4 mRNA Levels in Human HepatocytesDrug Metabolism and Disposition, 2007
- Cytokines, Inflammation, and PainInternational Anesthesiology Clinics, 2007
- Mutual repression between steroid and xenobiotic receptor and NF- B signaling pathways links xenobiotic metabolism and inflammationJournal of Clinical Investigation, 2006